Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Suboxone Film: Design Defects, Warning Claims, and Health Risks

2 minute read

Introduction

Suboxone, a medication that combines buprenorphine and naloxone, has been instrumental in helping individuals recover from opioid addiction. However, recent concerns over its film formulation have highlighted serious health risks, particularly regarding dental decay and tooth loss. [1] These risks, combined with allegations of design flaws and inadequate warnings, have led to growing scrutiny from both public health oAicials and the legal community. As litigation over Suboxone Film gains momentum, patients and healthcare providers are taking a closer look at the potential dangers of this widely used medication.

Background

The U.S. Food and Drug Administration (FDA) issued a warning in 2022, stating that buprenorphine-based medications, including Suboxone Film, were linked to severe dental problems, ranging from cavities to complete tooth loss. [2]  According to the FDA’s findings, the dissolvable nature of the film increases contact with teeth, potentially leading to prolonged exposure to substances that can damage enamel. Additionally, research published in Drug and Alcohol Dependence has highlighted the importance of proper post-use oral hygiene for patients using buprenorphine products, emphasizing that the drug’s formulation may contribute to dental erosion if precautions are not taken.

Lawsuits

In response to these issues, lawsuits have been filed alleging that Indivior, the manufacturer of Suboxone, failed to adequately warn patients and healthcare providers about the dental risks associated with the product. In February 2024, these lawsuits were consolidated into multidistrict litigation (MDL) under the U.S. District Court for the Northern District of Ohio. [3] One of the key legal arguments is that the design of Suboxone Film was inherently flawed and that a safer alternative design could have been developed. A December 2024 court decision further allowed claims of failure to warn and design defects to proceed, noting that there was suAicient evidence to suggest the manufacturer may have had access to information warranting stronger warnings or design changes. [4]

Conclusion

The Suboxone litigation highlights the need for greater accountability in the pharmaceutical industry. While the medication has been an important tool in the fight against opioid addiction, its potential side eAects cannot be overlooked.  [5] Studies in the Journal of the American Dental Association have underscored the long-term consequences of dental decay, which can impact overall health and quality of life. As these cases continue to unfold, the outcomes may set a precedent for improving patient safety in addiction treatments and ensuring more transparent communication about risks. [6] For patients, staying informed and discussing alternative treatment options with healthcare providers is crucial for making the best decisions for their recovery journey.

How We Can Help

At the Michael Lynch Firm, we’re handling cases for people who’ve been harmed by Suboxone film. If you or someone you care about has been injured, let us fight for you. You may be entitled to compensation for your medical bills, pain, and other damages. call us at 888-585-5970 or email brandon@mblynchfirm.com for a free consultation.

Date: January 24, 2025

Editor-in-Chief: Brandon Salter

Editor: Sonya Coenen

Citations

[1] https://www.fda.gov/safety/medical-product-safety-information/buprenorphine-drug-safety-communication-fda-warns-about-dental-problems-buprenorphine-medicines

[2] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-dental-problems-buprenorphine-medicines-dissolved-mouth-treat-opioid-use-disorder

[3] https://www.drugwatch.com/news/2024/02/05/suboxone-tooth-decay-lawsuits-consolidated-in-ohio-mdl/

[4] https://caselaw.findlaw.com/court/us-dis-crt-n-d-ohi-eas-div/116829507.html

[5] https://lifewellmd.com/side-eAects-of-suboxone-update/

[6] https://pmc.ncbi.nlm.nih.gov/articles/PMC3907320/

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta was marketed as a revolutionary drug to help people suffering from sickle cell disease manage their most painful symptoms. Oxbryta was manufactured by Global Blood Therapeutics (which was later bought by Pfizer) and approved by the FDA in 2019 for children and adults 12 years old and older. It was approved for children four years old and up in 2021. Alarming results from post-launch trials showed that Oxbryta may increase the symptoms of sickle cell disease instead of decreasing them.

read more
Mass Tort Abuses in the Mormon Church: A Legal Perspective

Mass Tort Abuses in the Mormon Church: A Legal Perspective

In recent years, the Church of Jesus Christ of Latter-day Saints (LDS), commonly known as the Mormon Church, has faced increasing legal scrutiny due to allegations of widespread abuse and institutional cover-ups. have come forward with claims of sexual, emotional, and physical abuse, many of which involve church leaders or institutions. These lawsuits have begun to take the form of mass tort claims, as multiple plaintiffs allege a systemic pattern of negligence and concealment within the organization.

read more
Understanding Copyright Law for OnlyFans Creators

Understanding Copyright Law for OnlyFans Creators

OnlyFans has become a booming platform for influencers and content creators, allowing them to monetize their work directly through subscriptions. However, with the rise of digital content creation comes the inevitable challenge of copyright infringement. Many OnlyFans creators find their exclusive content stolen and redistributed on unaffiliated websites without their permission. If you’re an OnlyFans influencer facing this issue, you may have legal recourse to protect your rights.

read more
Update on The New Maryland Child Sexual Abuse Law

Update on The New Maryland Child Sexual Abuse Law

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

read more
PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
×
What Our Clients Are Saying